Management of Nausea, Vomiting, and Mild Temperature in Adults
For an adult with nausea, vomiting, and mild fever without significant past medical history, start with a dopamine receptor antagonist (metoclopramide 10-20 mg or prochlorperazine 5-10 mg every 6 hours) on a fixed schedule, ensure adequate hydration, and evaluate for common infectious causes like gastroenteritis while monitoring for alarm symptoms that would require urgent evaluation. 1
Initial Assessment and Risk Stratification
Determine symptom acuity and severity immediately:
- Acute symptoms (lasting less than 7 days) with mild fever most commonly indicate viral gastroenteritis, foodborne illness, or other self-limiting viral syndromes 2
- Check for alarm symptoms requiring hospitalization: severe dehydration, inability to tolerate oral fluids, severe abdominal pain, altered mental status, or signs of intestinal obstruction 3
- In elderly patients or those from long-term care facilities, fever with nausea/vomiting may indicate bacteremia—look for hypotension, shaking chills, or band neutrophil count >1,500 cells/mm³ 4
Key historical features to elicit:
- Timing: Early morning episodes suggest cyclic vomiting syndrome; prodromal symptoms (sense of doom, anxiety, mental fog) lasting about 1 hour before vomiting onset support this diagnosis 4
- Triggers: Stress (70-80% of cyclic vomiting cases), sleep deprivation, menstrual cycle, recent infections, or surgery 4
- Medication review: Recent antibiotic starts (especially vancomycin), statins, or any new medications 5, 6
- Associated symptoms: Abdominal pain is present in most cyclic vomiting episodes and should not exclude this diagnosis; look for stereotypical clustering of symptoms like diaphoresis, flushing, headache, or bowel urgency 4
First-Line Pharmacologic Management
Initiate antiemetic therapy on a fixed schedule, not as-needed:
- Metoclopramide 10-20 mg PO/IV every 6 hours OR prochlorperazine 5-10 mg PO/IV every 6 hours 1
- Fixed scheduling maintains constant therapeutic levels and prevents emetic episodes more effectively than PRN dosing 1
- For mild acute gastroenteritis without severe dehydration, empiric antiemetic therapy is appropriate without extensive testing 3, 2
Supportive care:
- Fluid and electrolyte replacement—oral rehydration preferred if tolerated 2
- Small, frequent meals rather than large meals 1
- Cold foods better tolerated than hot foods due to less strong aromas 1
Escalation for Persistent Symptoms (24-48 Hours)
If symptoms persist despite first-line therapy:
- Add ondansetron 4-8 mg PO/IV every 8-12 hours (5-HT3 antagonist) 1, 7
- Consider adding dexamethasone 4-8 mg PO/IV daily to potentiate antiemetic effect 1
- For suspected cyclic vomiting syndrome in prodromal phase, early abortive therapy has higher success rates—educate patients to self-administer at symptom onset 4
Common pitfalls to avoid:
- Do not start with high doses in elderly patients; begin with reduced doses (e.g., metoclopramide 5-10 mg) 1
- Monitor for extrapyramidal symptoms with metoclopramide and prochlorperazine; have diphenhydramine 50 mg available for dystonic reactions 1
- Be aware that 5-HT3 antagonists like ondansetron can cause QT prolongation—avoid in patients with congenital long QT syndrome and monitor ECG in those with electrolyte abnormalities 7
When to Pursue Further Evaluation
Obtain basic laboratory testing if:
- Symptoms persist beyond 7 days (transition to chronic nausea/vomiting) 2
- Severe metabolic abnormalities suspected (check basic metabolic panel) 3
- Fever persists or worsens, suggesting bacterial infection rather than viral syndrome 4
- Patient appears severely ill or has signs of bacteremia (hypotension, altered mental status, severe abdominal pain) 4
Consider cyclic vomiting syndrome if:
- Stereotypical episodes of acute-onset vomiting lasting <7 days 4
- At least 3 discrete episodes in a year with 2 in prior 6 months, separated by at least 1 week of baseline health 4
- Personal or family history of migraine headaches (supportive criterion) 4
- If cyclic vomiting suspected, refer to gastroenterology for specialized management including prophylactic therapy 4
Refractory Cases
For symptoms not responding to dopamine antagonist plus 5-HT3 antagonist:
- Olanzapine 2.5-5 mg PO daily is particularly effective for refractory nausea 1
- Lorazepam 0.5-1 mg PO/IV every 4-6 hours for anxiety-related component 1
- Consider continuous IV/subcutaneous infusion if oral route not tolerated 1
Reevaluate within 24-48 hours: